Skip to main content
UniHealth

Doctor search

Akanksha Sharma, MD

Neurology · San Francisco

NPI 1124361712

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
9

Offices

9 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: Banner Gateway Medical Center · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Sharma’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence A169260 · Current

Licensed to practise in California · since 2020 · expires 2028-07-31 · University of Texas Southwestern Medical Center, Southwestern Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

  • Washington MDRE.ML.60365241Physician And Surgeon Residency Limited License · since 2013 · expires 2016-07-31
    ExpiredNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Banner Gateway Medical CenterGilbert, AZAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Banner Health, which runs 33 hospitals in 6 statesPatients rate it 3 of 5 · 73% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.39, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.197, Oct 2024 – Sep 2025
  • California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for Banner Gateway Medical Center

Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Banner Gateway Medical Center
Clostridium Difficile (C.Diff)Infections0.39BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.197BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.15 (0.24 to 2.07) · 980 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.97 (0.63 to 1.31)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths177.12 (117.95 to 236.29) · 49 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths8.8 · 35 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths10.5 · 98 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.5 · 434 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths12 · 111 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.9 · 2,070 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.39) · 2,971 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.24 (0.04 to 0.45) · 3,484 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.18 (0.97 to 5.4) · 610 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.41 (0 to 3.01) · 317 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.68 (1.13 to 4.23) · 572 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.54 (2.79 to 18.29) · 240 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.47 (1.05 to 7.9) · 295 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.57 (0.13 to 3.02) · 294 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.62 (0 to 1.35) · 2,934 casesNo differentJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.364No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.753No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.346No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.687No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.8 · 189 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-17.7 · 117 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits5.4 · 441 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 729 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.5 to 7) · 865 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (8.5 to 11.8) · 865 casesNo differentJan 2024 – Dec 2024
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.5 · 78 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits14.2 (10.6 to 18.7) · 641 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.2) · 596 casesNo differentJan 2024 – Dec 2024

What patients said (792 patients answered, 18% of those asked)

Patient survey stars by topic at Banner Gateway Medical Center
Cleanliness3
Nurse communication4
Doctor communication2
Communication about medicines3
Discharge information3
Overall hospital rating4
Quietness4
Recommend hospital4
Share of patients giving the best answer at Banner Gateway Medical Center
Room was "always" clean65%
Nurses "always" communicated well78%
Doctors "always" communicated well73%
Staff "always" explained57%
Yes, staff "did" give patients this information87%
Yes, staff "did" give patients information about help after discharge86%
Doctors "always" explained things so they could understand67%
Doctors "always" listened carefully70%
Doctors "always" treated them with courtesy and respect82%
Patients who gave a rating of "9" or "10" (high)69%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect87%
"Always" quiet at night63%
"YES", patients would definitely recommend the hospital73%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms87%
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp

Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at California Pacific Medical Ctr-Davies Campus Hosp
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.187BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.02 (0 to 2.09) · 232 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.98 (0.56 to 1.4)No differentJul 2022 – Jun 2024
Death rate for heart failure patientsComplications and deaths10 · 72 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.1 · 106 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.4 · 257 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.8 · 721 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.26 (0.03 to 0.49) · 2,031 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.25 (0.04 to 0.45) · 2,032 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.35 (0.94 to 5.76) · 419 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.41 (0 to 3) · 211 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.84 (1.24 to 4.44) · 414 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.95 (2.91 to 20.98) · 218 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.61 (1.47 to 9.75) · 198 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.74 (0.22 to 3.26) · 52 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.32 (0 to 1.28) · 1,461 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.6 · 58 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.756No differentOct 2024 – Sep 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22.1 · 91 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits65.3 · 84 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-26.6 · 115 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.4 · 142 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.5 · 55 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 25 casesNoneJul 2023 – Jun 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.7 to 1.3) · 312 casesNo differentJan 2024 – Dec 2024

What patients said (602 patients answered, 22% of those asked)

Patient survey stars by topic at California Pacific Medical Ctr-Davies Campus Hosp
Cleanliness4
Nurse communication2
Doctor communication4
Communication about medicines3
Discharge information3
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at California Pacific Medical Ctr-Davies Campus Hosp
Room was "always" clean75%
Nurses "always" communicated well73%
Doctors "always" communicated well79%
Staff "always" explained59%
Yes, staff "did" give patients this information86%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect85%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully71%
Nurses "always" treated them with courtesy and respect81%
"Always" quiet at night46%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms85%

Original Medicare doctor bills

$59,483

Medicare paid this office $59,483 for 116 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)49$13,747$113
Long return visit (40+ min)26$10,050$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$9,083$98
Initial hospital care with moderate level of medical decision making at least 75 minutes42$7,523$139
Return visit (30+ min)19$4,586$102
See all 8 services
Every Original Medicare service billed
Long return visit (40+ min)49$13,747$113
Long return visit (40+ min)26$10,050$150
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$9,083$98
Initial hospital care with moderate level of medical decision making at least 75 minutes42$7,523$139
Return visit (30+ min)19$4,586$102
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes20$3,168$65
Return visit (30+ min)29$3,046$71
New patient visit (60+ min)11$1,491$136

Who their Medicare patients are

116 Original Medicare patients in 2024. Average age 74 · Women 53% · Also on Medicaid 12% · Health risk score 2.50. Sicker patients than 9 in 10 peers; the typical neurology clinician is at 1.61.

Conditions among them: High blood pressure 70% · Stroke 43% · Cancer 41% · Depression 36% · Coronary heart disease 33% · Diabetes 29% · Chronic kidney disease 23% · Dementia 22% · Atrial fibrillation 20% · Heart failure 19% · COPD 17%.

The office billed $349,808, Medicare allowed $77,316 and paid $59,483; for 638 services of 25 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024116638742.50$349,808$59,483
202394511702.25$272,347$46,834
202270338702.34$184,426$32,758
202191508732.59$264,592$46,757
20203470702.05$34,499$7,218
20194157722.59$15,334$5,334

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 7 services

Original Medicare services billed in 2023
Return visit (30+ min)50$9,294$76
Long return visit (40+ min)30$7,488$115
Initial hospital care with moderate level of medical decision making at least 75 minutes32$5,090$141
Return visit (30+ min)14$4,640$108
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes15$4,386$100
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes29$3,911$66
Short return visit (20+ min)16$1,313$55

2022: 6 services

Original Medicare services billed in 2022
Long return visit (40+ min)32$6,774$119
Return visit (30+ min)43$6,115$80
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$4,300$88
Return visit (30+ min)12$2,485$113
Initial hospital care with moderate level of medical decision making at least 75 minutes12$2,371$169
Short return visit (20+ min)16$925$49

2021: 8 services

Original Medicare services billed in 2021
Return visit (30+ min)53$12,797$86
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes25$6,044$89
Short return visit (20+ min)35$3,384$55
Initial hospital care with same-day admission and discharge with straightforward or low level of medical decision making, per day at least 45 minutes12$2,961$114
Long return visit (40+ min)16$2,570$122
New patient visit (60+ min)13$2,105$162
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes18$1,936$62
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes13$1,801$113

2020: 1 service

Original Medicare services billed in 2020
Long return visit (40+ min)14$2,198$100

2019: 2 services

Original Medicare services billed in 2019
Initial hospital care with moderate level of medical decision making at least 75 minutes12$1,965$164
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes15$884$59

Drugs they prescribed that Part D paid

$92,101

Pharmacies billed $92,101 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 16% of their Part D prescriptions (32 of 204) in 2024. A higher opioid share than 9 in 10 peers; the typical neurology clinician is at 0%. Long-acting opioids: 47% of their opioid prescriptions.

178 generic and 26 brand-name prescriptions · $92,101 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Briviact12$16,388$1,366
Fentanyl11$560$51
Lacosamide15$437$29
Dexamethasone11$203$18
Oxycodone12$197$16
See all 6 drugs
Every Part D drug this clinician prescribed
Briviact12$16,388$1,366
Fentanyl11$560$51
Lacosamide15$437$29
Dexamethasone11$203$18
Oxycodone12$197$16
Gabapentin11$103$9

Year by year

Part D prescribing by year
20242043716% (32)13%$92,101
202313936None9%$16,278
20221473115% (22)20%$26,267
20212544610% (25)None$130,247
201915933None11%$12,847
201812728NoneNone$8,863
201781210% (0)None$4,991
201644None0% (0)32%$8,247
20143815NoneNone$902
20134014NoneNone$13,467

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Lacosamide12$879$73
Dexamethasone18$396$22
Levetiracetam11$322$29
Gabapentin12$134$11

2022: 3 drugs

Part D drugs prescribed in 2022
Eliquis13$11,394$876
Gabapentin23$436$19
Oxycodone11$351$32

2021: 6 drugs

Part D drugs prescribed in 2021
Vimpat25$23,210$928
Gabapentin21$442$21
Dexamethasone25$396$16
Baclofen11$339$31
Oxycodone12$339$28
Metoclopramide20$160$8

2019: 4 drugs

Part D drugs prescribed in 2019
Levetiracetam22$1,002$46
Zonisamide14$420$30
Dexamethasone12$187$16
Gabapentin18$173$10

2018: 1 drug

Part D drugs prescribed in 2018
Gabapentin11$110$10

2017: 1 drug

Part D drugs prescribed in 2017
Dexamethasone12$118$10

Money from drug and device companies

$327 in 2025

Industry payments by year
202545None$327
2024710$2,146$2,636
2023613$6,025$7,585
202256None$151
202168None$222
202022None$39
201911None$78

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
NovocureOptune Gio$185
2 payments
  • Meals · 2025-11-18 · $149
  • Meals for Optune Gio · 2025-10-30 · $35
Jazz PharmaceuticalsModeyso$101
1 payment
  • Meals for Modeyso · 2025-11-18 · $101
Merck Sharp & DohmeKeytruda$22
1 payment
  • Meals for Keytruda · 2025-02-05 · $22
EisaiLenvima$19
1 payment
  • Meals for Lenvima · 2025-02-10 · $19
See all 5 published payments
Every published payment
Jazz PharmaceuticalsMeals · 2025-11-18Modeyso$101
NovocureMeals · 2025-11-18None$149
NovocureMeals · 2025-10-30Optune Gio$35
EisaiMeals · 2025-02-10Lenvima$19
Merck Sharp & DohmeMeals · 2025-02-05Keytruda$22
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $2,636

Payments by company in 2024
Servier PharmaceuticalsNone$2,255
3 payments
  • Consulting · 2024-12-11 · $2,075
  • Travel · 2024-12-11 · $21
  • Meals · 2024-12-11 · $159
NovocureOptune$241
2 payments
  • Meals for Optune · 2024-05-28 · $170
  • Consulting · 2024-01-19 · $71
Octapharma USAOctagam Immune Globulin (Human)$33
1 payment
  • Meals for Octagam Immune Globulin (Human) · 2024-03-12 · $33
Lilly USAVerzenio$32
1 payment
  • Meals for Verzenio · 2024-04-11 · $32
Novartis PharmaceuticalsMekinist$30
1 payment
  • Meals for Mekinist · 2024-11-11 · $30
Daiichi SankyoEnhertu$25
1 payment
  • Meals for Enhertu · 2024-10-24 · $25
E.R. Squibb & Sons L.L.C.None$20
1 payment
  • Meals · 2024-11-20 · $20

2023: $7,585

Payments by company in 2023
NovocureOptune$7,462
6 payments
  • Travel · 2023-12-15 · $1,000
  • Honoraria · 2023-12-15 · $625
  • Meals for Optune · 2023-10-02 · $30
  • Honoraria for Optune · 2023-08-10 · $5,400
  • Travel for Optune · 2023-08-10 · $274
  • Meals for Optune · 2023-08-10 · $133
SeagenTukysa$32
1 payment
  • Meals for Tukysa · 2023-07-24 · $32
Bayer Healthcare PharmaceuticalsVitrakvi$29
1 payment
  • Meals for Vitrakvi · 2023-08-01 · $29
Octapharma USAPanzyga$26
1 payment
  • Meals for Panzyga · 2023-03-16 · $26
Foundation MedicineFoundationone Liquid Cdx$20
1 payment
  • Meals for Foundationone Liquid Cdx · 2023-09-20 · $20
Cumberland PharmaceuticalsSancuso$17
1 payment
  • Meals for Sancuso · 2023-11-27 · $17

2022: $151

Payments by company in 2022
Alexion PharmaceuticalsSoliris$52
2 payments
  • Meals for Soliris · 2022-03-07 · $23
  • Meals for Soliris · 2022-01-31 · $29
CSL BehringHizentra$34
1 payment
  • Meals for Hizentra · 2022-02-28 · $34
E.R. Squibb & Sons L.L.C.Opdivo$32
1 payment
  • Meals for Opdivo · 2022-10-31 · $32
NovocureNone$18
1 payment
  • Meals · 2022-01-10 · $18
ADC Therapeutics AmericaNone$15
1 payment
  • Meals · 2022-02-07 · $15

2021: $222

Payments by company in 2021
NovocureOptune$71
1 payment
  • Meals for Optune · 2021-11-19 · $71
NeurelisValtoco$46
2 payments
  • Meals for Valtoco · 2021-09-16 · $26
  • Meals for Valtoco · 2021-04-23 · $20
Daiichi SankyoTuralio$38
2 payments
  • Meals for Turalio · 2021-04-05 · $24
  • Meals for Turalio · 2021-01-25 · $15
BiogenNone$28
1 payment
  • Meals · 2021-03-29 · $28
Bayer HealthCare PharmaceuticalsVitrakvi$20
1 payment
  • Meals for Vitrakvi · 2021-08-02 · $20
Lilly USACyramza$18
1 payment
  • Meals for Cyramza · 2021-04-26 · $18

2020: $39

Payments by company in 2020
Lilly USACyramza$23
1 payment
  • Meals for Cyramza · 2020-11-16 · $23
AmgenXgeva$15
1 payment
  • Meals for Xgeva · 2020-12-02 · $15

2019: $78

Payments by company in 2019
NovocureOncology$78
1 payment
  • Meals for Oncology · 2019-02-28 · $78

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novocure GmbH · Ef-32 Trident A Pivotal Randomized, Open -Label Study of Tumor Treating Fields (Optune, 200khz) Concomitant With Radiation Therapy and Temazolomde for the Treatment of New Diagnosed Glioblastoma · 2023Their institution$49,022
Incyte Corporation · A Phase 2, Open-Label, Single-Arm, Multicenter Study To Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma Or Other Primary Central Nervous System Tumors Harboring Activating Fgfr1-3 Alterations (Fight-209) · 2023Their institution$48,549
Novocure GmbH · Ef-32 Trident A Pivotal Randomized, Open -Label Study of Tumor Treating Fields (Optune, 200khz) Concomitant With Radiation Therapy and Temazolomde for the Treatment of New Diagnosed Glioblastoma · 2024Their institution$38,187
Incyte Corporation · A Phase 2, Open-Label, Single-Arm, Multicenter Study To Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma Or Other Primary Central Nervous System Tumors Harboring Activating Fgfr1-3 Alterations (Fight-209) · 2024Their institution$34,394
Incyte Corporation · A Phase 2, Open-Label, Single-Arm, Multicenter Study To Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma Or Other Primary Central Nervous System Tumors Harboring Activating Fgfr1-3 Alterations (Fight-209) · 2025Their institution$20,102
Novocure GmbH · Ef-32 Trident A Pivotal Randomized, Open -Label Study of Tumor Treating Fields (Optune, 200khz) Concomitant With Radiation Therapy and Temazolomde for the Treatment of New Diagnosed Glioblastoma · 2025Their institution$15,877

Professional record

NPI
1124361712
Licence
AZ 54107, CA A169260, WA ML603265241, WA ML 60365241California A169260: Current · expires 2028-07-31Washington MDRE.ML.60365241: Expired
Trained
University of Texas Southwestern Medical School at Dallas, 2013
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Neurology (2084N0400X)
Mailing address
1580 Valencia St Fl 6, San Francisco, CA, 94110
NPI first listed
2013-04-01
NPI last updated
2026-08-08
NPI record certified
2026-08-08

This is when the NPI record was last certified, not a medical board exam.